EUCelLEX project brings together experts from various disciplines and jurisdictions to deliver an overall overview of the current landscape and future challenges for regulating and governing the procurement, use and applications of stem cells in Europe.
The teams of the consortium have previous collaborations for many years through their participation in research and infrastructure European projects (BBMRI Preparatory phase, BIOSHARE, StemBANCC, etc). Most of the partners have actively participated in the emergence of infrastructures for Biobanks in Europe or for Stem cells banking.
EU cannot be totally disconnected from what occurs in other countries out of Europe when controversies are at the forefront, and this is the case for the uses of Stem Cell in the context of health. That is why we decided to involve a team from McGill University (Canada), the Centre of Genomics and Policy: this center is at the forefront of major international stem cell policy initiatives and has unique expertise in international comparative law in the stem cell field.
- P1: Inserm (coordinator), FranceOpen or Close
Inserm (coordinator), France
INSERM is a public research organization entirely dedicated to human health. The institute coordinates the French national network of biobanks that harbors more than 300 collections of biological resources, including cells, stored in 50 centres in France.
P1a. The Team 4 “Genomics, biotherapies and public health: interdisciplinary approach” is part of the joint research unit UMR 1027: “Epidemiology and public health analyses: risks, chronic diseases and disability” It is an interdisciplinary team which addresses the implications of genomics for public health, especially issues pertaining to biobanks, genetic databases and innovative therapies.
E. Rial Sebbag is lawyer by background and has been developing a research activity in the
field of biobanks’ governance and for the legal issues raised by the uses of body elements in the context of health for years. She coordinates the EUCelLEX project.
A. Cambon Thomsen is specialized in human immunogenetics, she has a large experience in bioethics; she has been member of the European group on ethics (EGE). She led the team 4.
A. Blasimme, after his PhD in bioethics and STS (Science and Technology Studies) is currently running a postdoctoral funded by the Region Midi-Pyrénées on “Regenerative medicine and the governance of biomedical innovation”.
P1b. Inserm US 13 is a French infrastructure of biological resources that regroups 76 biobanks.
G. Dagher, senior investigator at Inserm (Paris, France) accomplished most of his career in pathophysiological and clinical research. He is currently the Director of BIOBANQUES infrastructure.
- P2: Leibniz University, GermanyOpen or Close
Leibniz University, Germany
The centre for Ethics and Law in the Life Sciences (CELLS) was founded in 2010 by members of Hanover Medical School (MHH) and Leibniz University Hanover (LUH) as a successor unit to LUH’s successful Medical Law and Bioethics Research Group. CELLS provides a platform for interdisciplinary research in the fields of medicine, law, philosophy and science. It is situated at and supported by both the Institute of Philosophy at LUH as well as the Institute for History, Ethics and Philosophy of Medicine at MHH.
Prof. Nils Hoppe, was a P.I. in the FP6 Science and Society project PropEur – “Property Regulation in European Science, Ethics and Law” He was co-coordinator, together with Christian Lenk, of the FP7 Health project Tiss.EU – “Evaluation of Legislation and Related Guidelines on the Procurement, Storage and Transfer of Human Tissues and Cells in the European Union – an Evidence-Based Impact Analysis”
- P3: Central European University, HungaryOpen or Close
Central European University, Budapest, Hungary
Central European University is a graduate institution in the social sciences, the humanities, law and management.
The Center for Ethics and Law in Biomedicine ( CELAB) at the CEU embraces manifold activities conducted by lawyers, philosophers, anthropologists, ethicists and other social scientists. The idea behind establishing CELAB was related to the recognition of a new and increasingly developing interdisciplinary field: the ethical, legal, and social implications of biotechnological advances.
Judit Sandor is Professor and director of the Centre for Ethics and Law in Biomedicine (CELAB), with and extensive experience in human rights and bioethics. She has participated in many European Union sponsored Research Projects.
Marton Varju is a research fellow at the Center for Ethics and Law in Biomedicine (CELAB). He is an expert in EU technology regulation and European human rights law.
- P4: Legal Pathways, NetherlandsOpen or Close
The Legal Pathways Institute for Health and Bio-Law is an independent legal research organization.
Its stated goal is to help the biomedical research community navigate the legal pathways that govern its cross border, multi- jurisdictional operations. The Institute’s areas of expertise include health law, pharmaceutical law, data protection law, technology transfer and biomedical research law, both at the national and the international level.
Dr J.Bovenberg, JD, LL.M, served on the Medical-Ethical Review Board of the Netherlands Cancer Institute. He currently serves on the Dutch Privacy Committee of the Netherlands National Pathology Records Archive and on the Ethics-Committee of TransEuro.
- P5: Oxford University, EnglandOpen or Close
Oxford University, England
The University of Oxford is the oldest university in the English–speaking world, having been at the forefront of teaching and research for nine centuries. With a current student population of over twenty thousand, the University’s standing as a centre for academic excellence continues, consistently achieving rankings within the top 6 universities in the world over the past decade. The University has built strong research and teaching profiles in e-science, social science, law and bioethics, recognising the importance of understanding the impact of science on society.
The Centre for Health, Law and Emerging Technologies at Oxford (HeLEX) is an interdisciplinary research centre that carries out applied research and is based at the Nuffield Department of Polulation Health at the University of Oxford. The centre specialises in investigating the relationships between law, ethics, and practice in the area of emerging technologies in health using empirical research, and analytical tools drawn from law and bioethics.
Dr Jane Kaye is the Director of HeLEX and obtained her degrees from the Australian National University (BA); University of Melbourne (LLB); and University of Oxford (DPhil). She was admitted to practice as a solicitor/barrister in 1997 and is member of the University of Oxford’s Faculty of Law. She specialises in data protection, privacy, human tissue and medical law.
- P6: Medical University of Graz, AustriaOpen or Close
Medical University of Graz, Austria
The Medical University of Graz (MUG) is associated with the University Clinics of Graz, with 1600 beds and 78000 patients/ year. Also, the EN/ISO 9001:2008 certified Biobank Graz is a facility of the Medical University Graz (MUG) that supports investigations of the causes of disease and the development of improvements in disease diagnosis and treatment. The Institute of Pathology (deputy head Kurt Zatloukal) is leading in the establishment of international biobank networks, interoperability of biobanks, standardization of sample-preanalytics, extraction, and clean-up of data from medical health records, databases and visual analytics, research project on rare cancers, and molecular pathology with major contributions to BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure European Research Infrastructure Consortium), SPIDIA (standardisation and improvement of generic pre-analytical tools and procedures for in-vitro diagnostics) and livSYSiPS (systems biology of network stress based on data generated from in vitro differentiated hepatocytes derived from individual-specific human iPS cells ).
Kurt Zatloukal is Professor of Pathology and coordinated the preparatory phase of the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) within the 7th EU framework programme (2008-2011).
Natalie Bordag works currently as a scientist at the Medical University of Graz for the EUCelLEX project and specialist health and nutrition scientist for metanomics GmbH. She is an expert for targeted and non-targeted metabolite profiling, known as metabolomics which is a powerful technology for functional stem cell characterization, in human healthcare, i.e. toxicology (in vivo, in vitro), biomarkers, cell line profiling.
- P7: National Political Sciences Foundation, FranceOpen or Close
The Fondation Nationale des Sciences Politiques (Sciences Po) is a fully-fledged, self-governing research university specialised in the social-economic sciences and the humanities. Based on a multi-disciplinary approach, it associates and combines skills and know-how from the different social sciences – in particular economy, history, political science and sociology and the humanities. The Centre for Political Research at Sciences Po (CEVIPOF), a Sciences Po-CNRS joint research unit (UMR 7048), is a leading European research centre in social science.
Virginie Tournay has a dual training in cellular biology (master’s degree) and in political studies (PhD). Her expertise is related to political history of biotechnologies; technological innovation and administrative practices related to emerging technologies based on human components etc. Her current research focuses on biotechnologies’ controversies and theories of institutions.
Adeline Néron is a PhD Researcher at the School for Advanced Studies in the Social Sciences and a Research Assistant at Sciences Po to work on the EuCelLEX project. With academic backgrounds in Philosophy, Biomedical Sciences, Research & Health Ethics and Science & Technology Studies, her current work focuses on governance of-and-by Bioethics.
- P8: Katholieke Universiteit Leuven, BelgiumOpen or Close
KU Leuven, Belgium
The Center for Biomedical Ethics and Law (www.cbmer.be) is part of the faculty of Medicine (University of Leuven) and is one of the leading bioethical and legal research centres in Europe. The researchers are closely working together with other European Centres and are participating in numerous national and international projects.
Herman Nys is director of the Centre for biomedical ethics (KUL) and law Member of the European Group of Ethics. He is WP leader in several EU projects.
Pascal Borry is Assistant Professor of Bioethics and Program Coordinator of the Erasmus Mundus Master of Bioethics (2006-2011, renewed 2011-2016). He is involved in various national and international projects related to the ethical and legal aspects of human genetics.
Mahsa Shabani is a PhD researcher at the Center for Biomedical Ethics and Law (University of Leuven). Her research activities revolve around ethical and legal challenges of genomics.
- P9 : McGill University, CanadaOpen or Close
McGill University, Canada
The Centre of Genomics and Policy (CGP) at McGill University (http://www.genomicsandpolicy.org), we promote prospective structuring and guidance for both research in genomic health sciences and its applications. Within a multidisciplinary perspective and in collaboration with national and international partners, the CGP analyzes the socio-ethical and legal norms influencing multiple aspects of the promotion and protection of human health. Currently, the CGP’s research covers six areas of genomics and policy: stem cell research and therapies, pediatrics, privacy, cancer, intellectual property, and biobanks (population genetics). These domains are approached using three guiding foundations: internationalization, policy development and knowledge transfer.
The Centre of Genomics and Policy (CGP) is a world-renowned hub for international law and policy analysis. Located in the Genome Quebec Innovation Centre at McGill University, the CGP is at the crossroads of the legal, medical and public policy fields. At the forefront of major national and international stem cell policy and ethics initiatives, the CGP is devoted to developing best practice guidelines for stem cell research and banking. The CGP houses its own intranet library, a valuable interactive research tool of 2269 coded, normative documents pertaining to stem cell and genetics research, in English, French and Spanish, from 64 countries (www.stemgen.org).
Pr. B. Knoppers is the Director of the CGP and holds the Canada Research Chair in Law and Medicine. She currently chairs the Policy Development Committee of the Stem Cell Network of Canada and the International Stem Cell Forum Ethics Working Party.